16 October 2024 in Salud, Ciencia y Tecnología - Serie de Conferencias
OGOdenis Fernández González
Odenis Fernández González
Basal cell carcinoma constitutes approximately 80% of non-melanocytic skin tumors and originates in the basal layer of the epidermis and its appendages. Genetic alterations that affect neoplastic development have been identified, caused by external physical or chemical agents, hereditary, chromosomal rearrangements, allelic loss and gene amplification. This article presents a white-skinned male individual, 64 years old, with a diagnosis of periocular basal cell carcinoma, who underwent a cytogenetic study of the tumor tissue and a mosaic chromosomal aneuploidy was identified.The presence of mosaic aneuploidy in patients with periocular basal cell carcinoma suggests that chromosomal aberrations may play an important role in tumor progression and aggressiveness. This finding highlights the need to integrate cytogenetic studies in the clinical evaluation of skin tumors, facilitating a better understanding of the underlying biological mechanisms, opening new avenues for therapeutic research.
8 May 2023 in Salud, Ciencia y Tecnología - Serie de Conferencias
Introduction: Prader-Willi syndrome, caused by the absence of expression of the paternal 15q11-13 region, is the first imprinting defect disorder described in humans. With an incidence of 1 in 10000-15000, its clinical phenotype characterized by hypotonia, obesity and hypogonadism overlaps with a group of genetically heterogeneous syndromes defined as Prader Willi-like syndrome or Prader Willi like. In this group, deletion 1p36, deletion 2p, deletion 6q, among others, are reported. Objective: to identify chromosomal aberrations in the conventional karyotype of patients with suspected Prader Willi syndrome. Methods: we analyzed the results of conventional karyotyping in lymphocytes, FISH molecular studies and methylation-based polymerase chain reaction of 112 patients referred during the period 2010-2019 for suspected Prader Willi syndrome. Results: Prader Willi syndrome was confirmed in 45,5 % of the patients. Chromosomal aberrations outside the 15q11.13 region were found in 5,3 % of cases including: chromosome 22 ring, trisomy 21 mosaic, 6p admixture, reverse sex and chromosome 21 inversion. Conclusions: In patients with Prader Willi phenotype, clinical suspicion is often not confirmed by molecular studies. Conventional karyotyping may reveal Prader Willi-like syndrome due to aberrations at sites involved in neuroendocrine control outside the 15q11.13 region. In these cases chromosomal diagnosis is essential for more effective prevention strategies as part of genetic counseling for patients and families.
31 December 2024 in Health Leadership and Quality of Life
Introduction: Pallister-Killian syndrome (PKS) is a rare multiple congenital anomaly/intellectual disability syndrome caused by tissue-restricted, mosaic tetrasomy 12p. The most common signs are facial dysmorphism, rhizomelic shortening of the extremities, pigmentary mosaic in skin; craniofacial manifestations include a ''coarse'' face with a flat profile and a wide forehead with sparse scalp hair in temporofrontal regions.Objective: To describe the karyotype and clinical manifestations in patients with suspected Pallister Killian Syndrome.Methods: Chromosomal studies were performed using conventional techniques in peripheral blood samples and skin samples in two patients, and a sample of amniotic fluid from a 17.3-week pregnant woman due to positive markers in the ultrasound. Peripheral blood cultures showed normal karyotypes in patients 1 and 2. Results: The fibroblast culture karyotypes of the patients studied reflected: Case 1: 47, XY+ i (12p) [8]/46 XY [10], Case 2:47, XY+ i (12p) (p10) [11] y Case 3: 47, XX + i (12p) [7]/46, XX [5] respectively. Conclusions:The SPK detected by conventional cytogenetics allowed a conclusive diagnosis in skin samples, despite the lack of molecular cytogenetic techniques, in those cases where chromosomal aberrations are restricted to a certain group of cells.
9 July 2026 in The Biologist
El mieloma múltiple es una neoplasia hematológica caracterizada por la proliferación clonal de células plasmáticas en la médula ósea, acompañada por la producción de inmunoglobulinas monoclonales y manifestaciones sistémicas. Su diagnóstico y manejo se basan en criterios clínicos, los cuales se complementan con estudios moleculares y citogenéticos que permiten una estratificación pronóstica más precisa. A pesar de los avances terapéuticos, sigue siendo una enfermedad incurable, debido a su marcada heterogeneidad clínica y biológica, que condiciona respuestas variables al tratamiento. En este trabajo se presenta el caso de una paciente con diagnóstico de mieloma múltiple en la cual se identificó una aberración cromosómica en mosaico compuesta por dos líneas celulares: una con monosomía del cromosoma X (45,X) y otra diploide normal (46,XX) a partir del cultivo del tumor. Este hallazgo que involucra los cromosomas sexuales en una paciente con mieloma múltiple representa un evento infrecuente y de interés clínico-genético, y resalta la importancia del estudio citogenético convencional en la evaluación integral de la enfermedad, especialmente para detectar alteraciones cromosómicas que podrían estar asociadas a una mayor inestabilidad genómica y heterogeneidad clonal.